A metric known as the Immunescore, which involves quantification of CD8+ T cells at the center and periphery of a tumor, was reported to be a strong predictor of OS that can complement traditional TNM staging or microsatellite instability (MSI) status in colorectal cancer [45–47]. The gene discussed is CD8A; the disease is neoplasm.